Direktorat Registrasi ObatValid

MELOXICAM

BPOM Number: GKL2540505510A1
Approved: 26 November 2025
Expiry: 25 November 2030
Form: Tablet

About This Registration

MELOXICAM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2540505510A1. Its current registration status is Valid, with the licence valid until 25 November 2030. The product is registered to BETA PHARMACON - INDONESIA. BPOM first approved this registration in November 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 10 STRIP @ 10 TABLET
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

BETA PHARMACON - INDONESIA
KAB. KARAWANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

BETA PHARMACON - INDONESIA
KAB. KARAWANG
primary
View profile →

Ingredients (1)

MELOXICAM

Market Intelligence

Owner Portfolio: BETA PHARMACON - INDONESIA holds 76 BPOM registrations
Manufacturer Scale: BETA PHARMACON - INDONESIA produces 76 registered products
Registration Age: Registered for 7 months

FDA Cross-Reference

via openFDA

Generic Name: MELOXICAM
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?